Consumer Reports Blasts SPF Claims Again, But Industry's Problems May Be Bigger
This article was originally published in The Rose Sheet
Executive Summary
The annual bad marks given to sunscreen brands from Consumer Reports for their SPF claims could be due to CR's nonconformity with FDA-prescribed test guidelines or could signal testing failures or other compliance problems in the industry. In any event, companies are hurrying to retest sunscreen formulas and validate their claims.
You may also be interested in...
SPF Testing Costs (And Variability) Could Be Reduced With In Vitro Method Uptake
Cosmetics Europe expects its in vitro method for SPF determination to be a published ISO standard within two to three years. The European Commission is behind in vitro sunscreen testing, and the method could significantly reduce costs and technical challenges while providing in vivo-equivalent results, the trade group says.
Octocrylene Now? Sunscreen Industry Under Growing Pressure As Environmental Concerns Mount
Lawmakers already are taking action to ban sales of oxybenzone- and octinoxate-containing sunscreens due to signals, however inconclusive, that the ingredients pose dangers to coral health. Now a new study suggests that octocrylene could be a concern as well.
FDA Tightlipped On Status Of ‘SPF Determination’ Study, But Issue Is A Concern
FDA’s 2016 request for contractor services to perform SPF testing on US-marketed sunscreen products has come up in litigation challenging brands’ SPF claims. The agency told Rose Sheet the issue of accurately labeled SPFs is a concern, but declined to provide further update on what it characterized as a pending matter.